Valuation : Viatris Inc.

Market Cap 18.77B 16.17B 15.16B 13.84B 26.08B 1,794B 26.16B 180B 70.19B 905B 70.46B 68.93B 3,002B P/E 2026 *
77.6x
P/E 2027 * 30.8x
Enterprise Value 30.83B 26.57B 24.91B 22.74B 42.84B 2,947B 42.98B 296B 115B 1,488B 116B 113B 4,932B EV / Sales 2026 *
2.09x
EV / Sales 2027 * 1.99x
Free-Float
91.44%
Yield 2026 *
3.11%
Yield 2027 * 3.19%
1 day-3.26%
1 week+0.12%
Current month-6.95%
1 month-8.51%
3 months+1.43%
6 months+9.44%
Current year+31.24%
1 week 16.19
Extreme 16.19
17.1
1 month 15.88
Extreme 15.88
18.39
Current year 12.19
Extreme 12.19
18.39
1 year 9.42
Extreme 9.425
18.39
3 years 6.85
Extreme 6.85
18.39
5 years 6.85
Extreme 6.85
18.39
10 years 6.85
Extreme 6.85
47.82
Manager TitleAgeSince
Chief Executive Officer 63 01/04/2023
Director of Finance/CFO 59 08/05/2026
Chief Tech/Sci/R&D Officer - 15/12/2023
Director TitleAgeSince
Director/Board Member 78 16/11/2020
Director/Board Member 78 16/11/2020
Director/Board Member 62 16/11/2020
Date Insider Type Main position Quantity % Market Cap.
8/15/26 A Fiscal year

Chief Administrative Officer

63,631 0.0054%
6/30/26 A Free

Director

2,756 0.0002%
6/30/26 A Free

Director

2,362 0.0002%
Change 5-day change 1-year change 3-year change Capi.($)
-3.26%+0.12%+56.96%+49.09% 18.77B
-0.13%-6.44%+60.47%+112.05% 1,047B
+0.85%-0.81%+52.77%+63.15% 646B
-1.03%-3.58%+22.87%+73.29% 451B
-1.46%-4.50%+37.43%+38.41% 355B
-0.72%-2.89%+21.86%+36.79% 291B
-1.19%-2.21%+1.35%+12.29% 252B
-1.05%-1.57%+51.40%+68.55% 234B
+0.08%-1.78%-17.64%-54.29% 203B
-2.14%-0.30%+29.42%+89.10% 181B
Average -1.02%-2.40%+31.69%+48.84% 367.8B
Weighted average by Cap. -0.50%-3.44%+38.75%+65.43%

Financials

2026 *2027 *
Net sales 14.78B 12.74B 11.94B 10.9B 20.54B 1,413B 20.6B 142B 55.28B 713B 55.5B 54.29B 2,365B 15.03B 12.95B 12.14B 11.08B 20.88B 1,436B 20.95B 144B 56.21B 725B 56.42B 55.2B 2,404B
Net income -27.26M -23.49M -22.02M -20.1M -37.87M -2.61B -37.99M -261M -102M -1.32B -102M -100M -4.36B 340M 293M 275M 251M 472M 32.48B 474M 3.26B 1.27B 16.4B 1.28B 1.25B 54.37B
Net Debt 12.07B 10.4B 9.75B 8.9B 16.76B 1,153B 16.82B 116B 45.12B 582B 45.3B 44.31B 1,930B 11.08B 9.55B 8.95B 8.17B 15.39B 1,059B 15.44B 106B 41.43B 534B 41.6B 40.69B 1,772B
Logo Viatris Inc.
Viatris Inc. is a global healthcare company. The Company markets branded and generic drugs, including complex drugs. The Company's segments include Developed Markets, Greater China, JANZ, and Emerging Markets. Its Developed Markets segment comprises its operations primarily in North America and Europe. The Company's Greater China segment includes its operations in mainland China, Taiwan and Hong Kong. The Company's JANZ segment consists of its operations in Japan, Australia and New Zealand. Its Emerging Markets segment encompasses its presence in more than 125 countries with developing markets and emerging economies including in Asia, Africa, Eastern Europe, Latin America and the Middle East as well as the Company's ARV franchise. It produces medicines for patients across a broad range of major therapeutic areas. From cardiovascular health to oncology, it offers treatment options across more than 10 major therapeutic areas covering a variety of noncommunicable and infectious diseases.
Employees
30,000
Date Price Change Volume
28/08/26 $16.34 -3.26% 6,218,655
27/08/26 $16.89 +0.24% 6,464,665
26/08/26 $16.85 +0.78% 7,402,327
25/08/26 $16.72 +1.09% 8,331,642
24/08/26 $16.54 +1.35% 4,980,491
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
10
Last Close Price
16.34USD
Average target price
18.50USD
Spread / Average Target
+13.22%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. VTRS Stock